Topic: Alzheimer.
Destination: The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer’s and related dementias:
· Drug Development RFP
· Program to Accelerate Clinical Trials (PACT) RFP
· Neuroimaging and CSF Biomarker Development RFP
· Prevention Pipeline RFP
Budget: Up to $600,000 or $3,000,000 depending on the program. Only direct costs are allowed.
Duration: One year with potential for follow-on funding.
Llena el siguiente formulario para recibir más información:
